Publication | Closed Access
Ruthenium–Arene Complexes of Curcumin: X-Ray and Density Functional Theory Structure, Synthesis, and Spectroscopic Characterization, in Vitro Antitumor Activity, and DNA Docking Studies of (<i>p</i>-Cymene)Ru(curcuminato)chloro
217
Citations
45
References
2011
Year
Crystal StructureChemoprevention StrategyChemistryHeterocycle ChemistryPharmaceutical ChemistryMedicinal ChemistryRuthenium–arene ComplexesAnti-cancer AgentRadiation OncologyCommercial Curcumin ReagentInorganic ChemistryCell LinesPharmacologyNatural Product SynthesisBiomolecular EngineeringNatural SciencesCoordination ComplexVitro Antitumor ActivityDna Docking StudiesMolecular ComplexMedicineDrug Discovery
The in vitro antiproliferative activity of the title compound on five tumor cell lines shows preference for the colon-rectal tumor HCT116, IC(50) = 13.98 μM, followed by breast MCF7 (19.58 μM) and ovarian A2780 (23.38 μM) cell lines; human glioblastoma U-87 and lung carcinoma A549 are less sensitive. A commercial curcumin reagent, also containing demethoxy and bis-demethoxy curcumin, was used to synthesize the title compound, and so (p-cymene)Ru(demethoxy-curcuminato)chloro was also isolated and chemically characterized. The crystal structure of the title compound shows (1) the chlorine atom linking two neighboring complexes through H-bonds with two O(hydroxyl), forming an infinite two-step network; (2) significant twist in the curcuminato, 20° between the planes of the two phenyl rings. This was also seen in the docking of the Ru-complex onto a rich guanine B-DNA decamer, where a Ru-N7(guanine) interaction is detected. This Ru-N7(guanine) interaction is also seen with ESI-MS on a Ru-complex-guanosine derivative.
| Year | Citations | |
|---|---|---|
Page 1
Page 1